Mila Gugnoni

Employment

• Azienda Ospedaliera Santa Maria Nuova di Reggio Emilia Post Doc
  2018 - Present

Education

• Alma Mater Studiorum - University of Bologna PhD
  2014 - 2018
• Alma Mater Studiorum - University of Bologna Master Degree
  2011 - 2014
• Alma Mater Studiorum - University of Bologna Bachelor Degree
  2007 - 2011

Projects & Funding

Projects & funding information is unavailable.

Publications (21)

• Exploring the transcriptional cooperation between RUNX2 and its associated elncRNA RAIN.
  Cell death & disease 2024 DOI: 10.1038/s41419-024-07058-x
  +Save
• Linc00941 fuels ribogenesis and protein synthesis by supporting robust cMYC translation in malignant pleural mesothelioma.
  Cancer letters 2024 DOI: 10.1016/j.canlet.2024.216950
  +Save
• Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
  Mila Gugnoni, Eugenia Lorenzini, Ítalo Faria do Valle +10 more
  Cell Death and Disease 2023 DOI: 10.1038/S41419-023-05603-8
  +Save
• BETi enhance ATGL expression and its lipase activity to exert their antitumoral effects in triple-negative breast cancer (TNBC) cells
  Journal of Experimental & Clinical Cancer Research 2023 DOI: 10.1186/S13046-022-02571-3
  +Save
• Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis
  Molecular Oncology 2023 DOI: 10.1002/1878-0261.13485
  +Save
• A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
  Cancer Communications 2022 DOI: 10.1002/cac2.12292
  +Save
• OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
  Journal of Experimental & Clinical Cancer Research 2022 DOI: 10.1186/s13046-022-02316-2
  +Save
• KAP1 is a new non-genetic vulnerability of malignant pleural mesothelioma (MPM)
  NAR Cancer 2022 DOI: 10.1093/NARCAN/ZCAC024
  +Save
• No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
  Cancers 2021 DOI: 10.3390/cancers13205201
  +Save
• How Can We Treat Vulvar Carcinoma in Pregnancy? A Systematic Review of the Literature
  Cancers 2021 DOI: 10.3390/cancers13040836
  +Save
• Linc00941 is a novel TGFβ target that primes papillary thyroid cancer metastatic behavior by regulating the expression of Cadherin 6
  Thyroid 2020 DOI: 10.1089/thy.2020.0001
  +Save
• HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
  Journal of Experimental & Clinical Cancer Research 2019 DOI: 10.1186/s13046-019-1350-5
  +Save
• RAIN Is a Novel Enhancer-Associated lncRNA That Controls RUNX2 Expression and Promotes Breast and Thyroid Cancer.
  Molecular cancer research : MCR 2019 DOI: 10.1158/1541-7786.mcr-19-0564
  +Save
• Long Noncoding RNA and Epithelial Mesenchymal Transition in Cancer.
  International journal of molecular sciences 2019 DOI: 10.3390/ijms20081924
  +Save
• Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
  Oncotarget 2018 DOI: 10.18632/oncotarget.22805
  +Save
• Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy
  Oncogene 2017 DOI: 10.1038/onc.2016.237
  +Save
• RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
  Valentina Sancisi, Gloria Manzotti, Mila Gugnoni +11 more
  Nucleic Acids Research 2017 DOI: 10.1093/nar/gkx802
  +Save
• Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer.
  2016 DOI: 10.1038/cddis.2016.415
  +Save
• Soluble epidermal growth factor receptors (sEGFRs) in cancer: Biological aspects and clinical relevance
  International Journal of Molecular Sciences 2016 DOI: 10.3390/ijms17040593
  +Save
• The extent of whole-genome copy number alterations predicts aggressive features in primary melanomas
  Pigment Cell and Melanoma Research 2016 DOI: 10.1111/pcmr.12436
  +Save